Randomized, controlled trial with interferon-alpha plus ribavirin with and without amantadine sulphate in patients with chronic hepatitis C relapsing after previous successful antiviral treatment

被引：2
|
作者：
Teuber, G
Pascu, M
Lafrenz, M
Weidenbach, H
Schoelmrich, J
Wietzke-Braun, P
Arnold, R
Pausch, J
Lock, G
Zeuzem, S
机构：
[1] UNIKlin, Med Klin 2, D-60590 Frankfurt, Germany
[2] Klin & Poliklin Innere Med, D-18055 Rostock, Germany
[3] Univ Klinikum Charite, D-13352 Berlin, Germany
[4] Med UNI Klin, D-89081 Ulm, Germany
[5] UniKlin, Gastroenterol Abt, Gottingen, Germany
[6] UNIKlin, Klin & Poliklin Innere Med, D-93042 Regensburg, Germany
[7] UNIKlin, Zentrum Innere Med, D-35033 Marburg, Germany
[8] Staedt Klinikum, Med Klin 1, D-34125 Kassel, Germany
[9] UNIKlin, Med Klin 2, D-60590 Frankfurt, Germany
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80472-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
472
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [31] RETRACTED: The role of triple therapy with amantadine sulphate plus ribavirin and interferon-alpha2a on chronic hepatitis C patients (Retracted Article)
    Abulfutuh, AR
    Morsy, M
    Solyman, AEG
    El Hendawy, S
    El Desouky, M
    El Hadad, S
    Kamel, M
    GASTROENTEROLOGY, 2003, 124 (04) : A777 - A777
  • [32] Retreatment with pegylated interferon-alpha2b plus ribavirin in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interfermis combined with ribavirin
    Teuber, G
    Kallinowski, B
    Niederau, C
    Klinker, H
    Galle, PR
    Zankel, M
    Zeuzem, S
    GASTROENTEROLOGY, 2003, 124 (04) : A768 - A768
  • [33] Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naive patients with chronic hepatitis C
    Thuluvath, PJ
    Maheshwari, A
    Mehdi, J
    Fairbanks, KD
    Wu, LLW
    Gelrud, LG
    Ryan, MJ
    Anania, FA
    Lobis, IF
    Black, M
    GUT, 2004, 53 (01) : 130 - 135
  • [34] Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine
    Stauber, RE
    Hofer, H
    Hackl, F
    Schütze, K
    Datz, C
    Hegenbarth, K
    Jessner, W
    Steindl-Munda, P
    Ferenci, P
    WIENER KLINISCHE WOCHENSCHRIFT, 2004, 116 (15-16) : 530 - 535
  • [35] Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine
    Rudolf E Stauber
    Harald Hofer
    Franz Hackl
    Kurt Schüze
    Christian Datz
    Karin Hegenbarth
    Wolfgang Jessner
    Petra Steindl-Munda
    Peter Ferenci
    Wiener Klinische Wochenschrift, 2004, 116 : 530 - 535
  • [36] Prospective randomized study of peginterferon alpha-2a, ribavirin and amantadine vs peginterferon alpha-2a plus ribavirin, in hepatitis C patients now responders or relapsers to interferon-alpha and ribavirin
    Cheinquer, H.
    Pessoa, M.
    Almeida, P.
    Silva, G.
    Patelli, M.
    Parana, R.
    Parise, E.
    Lacerda, M.
    Pernambuco, J.
    Pedrosa, S.
    Teixeira, R.
    Tatsch, E.
    Sette, H.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S209 - S209
  • [37] Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-α and/or ribavirin
    Di Martino, V
    Boudjema, H
    Delacour, T
    Cazier, A
    Caron, C
    Coutarel, P
    Dumouchel, P
    Cadranel, JF
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) : 830 - 831
  • [38] High-dose interferon-alpha(2b) for re-treatment of nonresponders or relapsing patients with chronic hepatitis C - A controlled randomized trial
    Bonkovsky, HL
    Clifford, BD
    Smith, LJ
    Allan, C
    Banner, B
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (01) : 149 - 154
  • [39] PEGYLATED INTERFERON ALPHA PLUS RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS C IN PSORIATIC PATIENTS
    Tomasiewicz, Krzysztof
    Modrzewska, Romana
    HEPATOLOGY, 2008, 48 (04) : 907A - 907A
  • [40] IFN plus ribavirin and amantadine for IFN-insensitive patients with chronic hepatitis C: Results of a multicenter, randomized, controlled trial
    Andreone, P
    Gramenzi, A
    Cursaro, C
    Pirraglia, C
    Verrucchi, G
    Attard, L
    Boccia, S
    Giacomoni, PL
    Felline, F
    Biselli, M
    Loggi, E
    Lorenzini, S
    Bernardi, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 124 - 124
12345